{"name": "Human Genome Sciences",
 "permalink": "human-genome-sciences",
 "crunchbase_url": "http://www.crunchbase.com/company/human-genome-sciences",
 "homepage_url": "http://www.hgsi.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Drug Developer",
 "created_at": "Mon Aug 03 23:38:37 UTC 2009",
 "updated_at": "Thu Aug 19 02:34:48 UTC 2010",
 "overview": "\u003Cp\u003EHGS seeks to apply science and medicine to bring innovative drugs to patients with unmet medical needs.\u003C/p\u003E\n\n\u003Cp\u003EAs of August 2009, The company is poised for the market with a clinical pipeline that includes three products in late-stage development:\u003C/p\u003E\n\n\u003Cp\u003EBENLYSTA\u00e2\u201e\u00a2 (formerly LymphoStat-B\u00c2\u00ae) has successfully completed one of two pivotal Phase 3 trials in systemic lupus, and we expect results from the second Phase 3 trial of BENLYSTA in November 2009;\u003C/p\u003E\n\n\u003Cp\u003EZALBIN\u00e2\u201e\u00a2 (formerly Albuferon\u00c2\u00ae) has successfully completed two Phase 3 trials in chronic hepatitis C, and we expect the filing of global marketing applications for ZALBIN in fall of this year;\u003C/p\u003E\n\n\u003Cp\u003ERaxibacumab (ABthrax\u00e2\u201e\u00a2) is currently pending priority review by FDA for inhalation anthrax.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[98,
       83],
      "assets/images/resized/0005/5112/55112v2-max-150x150.png"],
     [[98,
       83],
      "assets/images/resized/0005/5112/55112v2-max-250x250.png"],
     [[98,
       83],
      "assets/images/resized/0005/5112/55112v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "H.",
      "last_name": "Thomas Watkins",
      "permalink": "h-thomas-watkins",
      "image": null}},
   {"is_past": false,
    "title": "Executive Vice President \u0026 CFO",
    "person":
     {"first_name": "David",
      "last_name": "P. Southwell",
      "permalink": "david-p-southwell",
      "image": null}},
   {"is_past": true,
    "title": "Senior Scientist",
    "person":
     {"first_name": "Guo",
      "last_name": "Liang Yu",
      "permalink": "guo-liang-yu",
      "image":
       {"available_sizes":
         [[[95,
            95],
           "assets/images/resized/0026/7372/267372v1-max-150x150.jpg"],
          [[95,
            95],
           "assets/images/resized/0026/7372/267372v1-max-250x250.jpg"],
          [[95,
            95],
           "assets/images/resized/0026/7372/267372v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "14200 Shady Grove Road",
    "address2": "",
    "zip_code": "20850",
    "city": "Rockville",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": 39.092233,
    "longitude": -77.206829}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}